Databases
Comprehensive coverage on biopharmaceutical companies, universities, drugs, clinical trials, disease epidemiology, patent expiry, drug sales and projections, regulatory, generics, drug master files and manufacturing attributes. Simple search navigations, customizable display and exports meets different clientele requirements. Pre-defined analytics with ready-to-use exports, and alerts functionality brings you requires data daily basis.
Intelligence Platforms
Company competitive intelligence tool provides similar companies by Headquarters, Disease Area, Nature of Molecule, Pipeline/Approved stages and Business Type. Provides ready-to-use templates by company with basic details, financials, key people, drug sales and performance Metrix.
Clinical Trial Planner tool provides subjects/sites/investigators availability by Drug Indication, Phase and Nature of Molecule, and Enrollment Size.
Clinical Trial Planner tool provides subjects/sites/investigators availability by Drug Indication, Phase and Nature of Molecule, and Enrollment Size.
Industry Trends
Instant data view on global pipeline and approved drugs, associated companies, clinical trials, trial sites, investigators, drug price, drug sales and regulatory information for the required data set. Data visualization and analytics based on the content helps you with ready-to-use exports and analytics. Dynamic updates and new additions as per your subscribed content saves time and money.
Disease Landscape
Database covers major unmet need and rare indications by incidence, prevalence, disease characteristics, and market size for more than 40+ countries. Customized insights on current treatments, promising pipeline drugs, active companies/institutes/universities and active trial sponsors/collaborators. Strategic data representation with drug sales and forecast, patent landscape, review designations, strategic deals and licensing opportunity data.
Monthly Newsletter
Doloxe’s newsletter covers advanced therapies companies financing, licensing deals, merger & acquisitions, drug development, regulatory updates, key people hiring and new companies. These will act as business leads for service provides and investor companies.